| Candidiasis |
1 |
1 |
| Fungal Infection |
0 |
0.95 |
| Skin and Soft Tissue Infection |
0 |
0.92 |
| Vulvovaginal Candidiasis |
0 |
0.99 |
| Candida |
0 |
0.53 |
| Primary Care |
0 |
0.3 |
| Vagina |
0 |
0.15 |
| Antifungal |
0 |
0.07 |
| Artificial Intelligence |
0 |
0.07 |
| Laser |
0 |
0.07 |
| Mass Spectrometry |
0 |
0.07 |
| NHS |
0 |
0.07 |
| Outpatient Clinic |
0 |
0.07 |
| Pandemic |
0 |
0.07 |
| Sexual Health |
0 |
0.07 |
| Sexually Transmitted Infection |
0 |
0.07 |
| COVID-19 |
0 |
0.06 |
| Health Care Reform |
0 |
0.06 |
| Healthcare and Medical Technology |
0 |
0.06 |
| Vaginitis |
0 |
0.06 |